这是一篇来自已证抗体库的有关人类 PLC-gamma1 (PLC-gamma1) 的综述,是根据52篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PLC-gamma1 抗体。
PLC-gamma1 同义词: NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1

圣克鲁斯生物技术
小鼠 单克隆(E-12)
  • 免疫印迹; 人类; 图 1b
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, sc-7290)被用于被用于免疫印迹在人类样本上 (图 1b). Mol Cell Proteomics (2018) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 小鼠; 图 12a
圣克鲁斯生物技术PLC-gamma1抗体(SantaCruz, SC-7290)被用于被用于免疫印迹在小鼠样本上 (图 12a). Neurobiol Aging (2017) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 小鼠; 图 5c
圣克鲁斯生物技术PLC-gamma1抗体(Santa cruz, Sc-7290)被用于被用于免疫印迹在小鼠样本上 (图 5c). Cell Immunol (2017) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 小鼠; 图 4a
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, sc-7290)被用于被用于免疫印迹在小鼠样本上 (图 4a). Int J Mol Sci (2017) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 人类; 1:200; 图 s5
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz Biotechnology, sc-7290)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 s5). Nat Commun (2016) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 大鼠; 图 1f
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz Biotechnology, SC-7290)被用于被用于免疫印迹在大鼠样本上 (图 1f). PLoS ONE (2016) ncbi
小鼠 单克隆(E-12)
  • 免疫沉淀; domestic rabbit; 图 s2
  • 免疫印迹; domestic rabbit; 图 s2
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, sc-7290)被用于被用于免疫沉淀在domestic rabbit样本上 (图 s2) 和 被用于免疫印迹在domestic rabbit样本上 (图 s2). FASEB J (2016) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, SC-7290)被用于被用于免疫印迹在人类样本上浓度为1:500. J Neurodegener Dis (2013) ncbi
小鼠 单克隆(1F1)
  • 免疫印迹; 人类; 1:200; 图 2b
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, sc-58407)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 2b). Nat Commun (2015) ncbi
小鼠 单克隆(E-12)
  • 免疫印迹; domestic rabbit; 图 1a
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz Biotechnology, sc-7290)被用于被用于免疫印迹在domestic rabbit样本上 (图 1a). Physiol Rep (2015) ncbi
小鼠 单克隆(E-12)
  • 免疫沉淀; 人类; 图 4
圣克鲁斯生物技术PLC-gamma1抗体(Santa Cruz, E-12)被用于被用于免疫沉淀在人类样本上 (图 4). Cell Signal (2015) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3
赛默飞世尔PLC-gamma1抗体(Invitrogen, 44-696G)被用于被用于免疫印迹在人类样本上 (图 3). Oncogene (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔PLC-gamma1抗体(生活, 44-696 G)被用于. elife (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5i
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5i). EMBO Mol Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2821)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6e). Commun Biol (2021) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 小鼠; 1:1000; 图 6e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 5690)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6e). Commun Biol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(CST, 2821)被用于被用于免疫印迹在小鼠样本上 (图 5e). Cell Rep (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s10a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2821S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s10a). Science (2020) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 小鼠; 1:1000; 图 3e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3e). EMBO Mol Med (2020) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 小鼠; 1:1000; 图 3e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 5690)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3e). EMBO Mol Med (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 ev1c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 ev1c). EMBO Mol Med (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2821)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). Front Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2822)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). Front Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s1f
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2822)被用于被用于免疫印迹在人类样本上 (图 s1f). Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 3871S)被用于被用于免疫印迹在人类样本上 (图 3a). J Immunol (2019) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类; 图 s6b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 5690)被用于被用于免疫印迹在人类样本上 (图 s6b). Breast Cancer Res (2019) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 人类; 图 s6b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于免疫印迹在人类样本上 (图 s6b). Breast Cancer Res (2019) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于免疫印迹在人类样本上 (图 2b). Cancer Cell Int (2019) ncbi
domestic rabbit 单克隆(D25A9)
  • 免疫印迹; 人类; 1:2000; 图 8a
  • 免疫印迹; 小鼠; 1:2000; 图 8b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(CST, 8713T)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 8a) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 8b). J Cell Sci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s3e
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 3871)被用于被用于免疫印迹在小鼠样本上 (图 s3e). Immunity (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 仓鼠; 1:1000; 图 8a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(CST, 2822)被用于被用于免疫印迹在仓鼠样本上浓度为1:1000 (图 8a). J Gen Virol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 仓鼠; 1:2000; 图 8a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2821)被用于被用于免疫印迹在仓鼠样本上浓度为1:2000 (图 8a). J Gen Virol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 3871)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3c). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 人类; 1:1000; 图 3a
  • 免疫印迹; 小鼠; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 14008)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3c). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(D6M9S)
  • 流式细胞仪; 小鼠; 图 6d
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于流式细胞仪在小鼠样本上 (图 6d). Nat Immunol (2018) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类; 图 9a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 5690)被用于被用于免疫印迹在人类样本上 (图 9a). Int J Biochem Cell Biol (2018) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于免疫印迹在人类样本上 (图 6a). Mol Cell Proteomics (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 4510)被用于被用于免疫印迹在小鼠样本上 (图 5c). Cell Immunol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 3d
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(cell signalling, 3871P)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 3d). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2822)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). FASEB J (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). FASEB J (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 s9b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 3871)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s9b). Nat Commun (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 e3
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(cell signalling, 2821)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 e3). Nature (2016) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 小鼠; 1:1000; 图 e3
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(cell signalling, 5690)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 e3). Nature (2016) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫细胞化学; 人类; 图 s12
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 14008BF)被用于被用于免疫细胞化学在人类样本上 (图 s12). Mol Biol Cell (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2822)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 st1
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2821)被用于被用于免疫印迹在人类样本上 (图 5b). Am J Physiol Heart Circ Physiol (2016) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 1:50; 图 3b
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, 2822)被用于被用于其他在人类样本上浓度为1:50 (图 3b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). BMC Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Mol Med Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 8
  • 免疫印迹; 人类; 1:1000; 图 6
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2822S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 8) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 8
  • 免疫印迹; 人类; 1:1000; 图 6
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2821L)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 8) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在人类样本上 (图 7). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类; 图 7
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 5690)被用于被用于免疫印迹在人类样本上 (图 7). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2821)被用于被用于免疫印迹在人类样本上 (图 2). Mol Cancer Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2822)被用于被用于免疫印迹在人类样本上 (图 2). Mol Cancer Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s4c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 3871)被用于被用于免疫印迹在小鼠样本上 (图 s4c). J Immunol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell signaling, 2821)被用于被用于免疫印迹在人类样本上 (图 2). BMC Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在小鼠样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2c
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 2821)被用于被用于免疫印迹在小鼠样本上 (图 2c). Exp Hematol (2016) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 5690)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2015) ncbi
domestic rabbit 单克隆(D25A9)
  • 免疫印迹; 人类; 1:1000; 图 11
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, D25A9)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 11). Anticancer Agents Med Chem (2016) ncbi
domestic rabbit 单克隆(D6M9S)
  • 免疫印迹; 小鼠; 1:1000; 图 7g
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, 14008)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7g). Nat Commun (2015) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling, D9H10)被用于被用于免疫印迹在人类样本上 (图 1a). Nature (2015) ncbi
domestic rabbit 单克隆(D9H10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司PLC-gamma1抗体(Cell Signaling Technology, D9H10)被用于被用于免疫印迹在人类样本上. PLoS Med (2015) ncbi
碧迪BD
小鼠 单克隆(K86-689.37)
  • 流式细胞仪; 人类; 图 s1c
碧迪BDPLC-gamma1抗体(BD, 558490)被用于被用于流式细胞仪在人类样本上 (图 s1c). J Exp Med (2018) ncbi
文章列表
  1. Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson S, et al. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO Mol Med. 2021;13:e13929 pubmed 出版商
  2. Shang P, Stepicheva N, Teel K, McCauley A, Fitting C, Hose S, et al. βA3/A1-crystallin regulates apical polarity and EGFR endocytosis in retinal pigmented epithelial cells. Commun Biol. 2021;4:850 pubmed 出版商
  3. Abu Odeh M, Zhang Y, Reilly S, Ebadat N, Keinan O, Valentine J, et al. FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes. Cell Rep. 2021;35:109331 pubmed 出版商
  4. Cook S, Comrie W, Poli M, Similuk M, Oler A, Faruqi A, et al. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020;369:202-207 pubmed 出版商
  5. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed 出版商
  6. Buhl E, Djudjaj S, Klinkhammer B, Ermert K, Puelles V, Lindenmeyer M, et al. Dysregulated mesenchymal PDGFR-β drives kidney fibrosis. EMBO Mol Med. 2020;12:e11021 pubmed 出版商
  7. Liu T, Han S, Dai Q, Zheng J, Liu C, Li S, et al. IL-17A-Mediated Excessive Autophagy Aggravated Neuronal Ischemic Injuries via Src-PP2B-mTOR Pathway. Front Immunol. 2019;10:2952 pubmed 出版商
  8. Lundby A, Franciosa G, Emdal K, Refsgaard J, Gnosa S, Bekker Jensen D, et al. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites. Cell. 2019;179:543-560.e26 pubmed 出版商
  9. Gu C, Wang L, Zurawski S, Oh S. Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation. J Immunol. 2019;: pubmed 出版商
  10. Kennedy S, Han J, Portman N, Nobis M, Hastings J, Murphy K, et al. Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast Cancer Res. 2019;21:43 pubmed 出版商
  11. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed 出版商
  12. Zhang S, Liu W, Yang Y, Sun K, Li S, Xu H, et al. Tmem30a Deficiency in endothelial cells impairs cell proliferation and angiogenesis. J Cell Sci. 2019;: pubmed 出版商
  13. Arora H, Wilcox S, Johnson L, Munro L, Eyford B, Pfeifer C, et al. The ATP-Binding Cassette Gene ABCF1 Functions as an E2 Ubiquitin-Conjugating Enzyme Controlling Macrophage Polarization to Dampen Lethal Septic Shock. Immunity. 2019;50:418-431.e6 pubmed 出版商
  14. Vrijens P, Noppen S, Boogaerts T, Vanstreels E, Ronca R, Chiodelli P, et al. Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway. J Gen Virol. 2019;100:583-601 pubmed 出版商
  15. Duan S, Koziol White C, Jester W, Nycholat C, Macauley M, Panettieri R, et al. CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen. J Clin Invest. 2019;129:1387-1401 pubmed 出版商
  16. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed 出版商
  17. Yin R, Guo L, Gu J, Li C, Zhang W. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis. Int J Biochem Cell Biol. 2018;97:43-51 pubmed 出版商
  18. Kostas M, Haugsten E, Zhen Y, Sørensen V, Szybowska P, Fiorito E, et al. Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors. Mol Cell Proteomics. 2018;17:850-870 pubmed 出版商
  19. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed 出版商
  20. Wang H, Lee K, Pei Z, Khan A, Bakshi K, Burns L. PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis. Neurobiol Aging. 2017;55:99-114 pubmed 出版商
  21. Zhou X, Packialakshmi B, Xiao Y, Nurmukhambetova S, Lees J. Progression of experimental autoimmune encephalomyelitis is associated with up-regulation of major sodium transporters in the mouse kidney cortex under a normal salt diet. Cell Immunol. 2017;317:18-25 pubmed 出版商
  22. Honjoh C, Chihara K, Yoshiki H, Yamauchi S, Takeuchi K, Kato Y, et al. Association of C-Type Lectin Mincle with FcεRIβγ Subunits Leads to Functional Activation of RBL-2H3 Cells through Syk. Sci Rep. 2017;7:46064 pubmed 出版商
  23. Ting W, Huang C, Jiang C, Lin Y, Chung L, Shen C, et al. Treatment with 17?-Estradiol Reduced Body Weight and the Risk of Cardiovascular Disease in a High-Fat Diet-Induced Animal Model of Obesity. Int J Mol Sci. 2017;18: pubmed 出版商
  24. Yang G, Zhao Z, Qin T, Wang D, Chen L, Xiang R, et al. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017;31:2001-2012 pubmed 出版商
  25. Chen C, Huang J, Wang C, Tahara S, Zhou L, Kondo Y, et al. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. Nat Commun. 2017;8:13882 pubmed 出版商
  26. Mueller A, van Velthoven C, Fukumoto K, Cheung T, Rando T. Intronic polyadenylation of PDGFR? in resident stem cells attenuates muscle fibrosis. Nature. 2016;540:276-279 pubmed 出版商
  27. Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
  28. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  29. Egholm C, Khammy M, Dalsgaard T, Mazur A, Tritsaris K, Hansen A, et al. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2016;311:H1214-H1224 pubmed 出版商
  30. Zhong W, Yi Q, Xu B, Li S, Wang T, Liu F, et al. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival. Nat Commun. 2016;7:12702 pubmed 出版商
  31. Padhan N, Nordling T, Sundstrom M, Akerud P, Birgisson H, Nygren P, et al. High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer. BMC Cancer. 2016;16:683 pubmed 出版商
  32. Stucky A, Bakshi K, Friedman E, Wang H. Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling. PLoS ONE. 2016;11:e0160585 pubmed 出版商
  33. Gao G, He J, Nong L, Xie H, Huang Y, Xu N, et al. Periodic mechanical stress induces the extracellular matrix expression and migration of rat nucleus pulposus cells by upregulating the expression of intergrin ?1 and phosphorylation of downstream phospholipase C?1. Mol Med Rep. 2016;14:2457-64 pubmed 出版商
  34. Blas Rus N, Bustos Morán E, Perez de Castro I, de Carcer G, Borroto A, Camafeita E, et al. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nat Commun. 2016;7:11389 pubmed 出版商
  35. Rorsman C, Tsioumpekou M, Heldin C, Lennartsson J. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling. J Biol Chem. 2016;291:11608-18 pubmed 出版商
  36. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed 出版商
  37. Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed 出版商
  38. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed 出版商
  39. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  40. Ishibashi T, Yaguchi A, Terada K, Ueno Yokohata H, Tomita O, Iijima K, et al. Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells. Exp Hematol. 2016;44:177-88.e5 pubmed 出版商
  41. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed 出版商
  42. Ksionda O, Melton A, Bache J, Tenhagen M, Bakker J, Harvey R, et al. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines. Oncogene. 2016;35:3658-68 pubmed 出版商
  43. Freedman T, Tan Y, Skrzypczynska K, Manz B, Sjaastad F, Goodridge H, et al. LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. elife. 2015;4: pubmed 出版商
  44. Shi J, Miralles F, Birnbaumer L, Large W, Albert A. Store depletion induces Gαq-mediated PLCβ1 activity to stimulate TRPC1 channels in vascular smooth muscle cells. FASEB J. 2016;30:702-15 pubmed 出版商
  45. Sugiyama S, Yoshino Y, Kuriyama S, Inoue M, Komine K, Otsuka K, et al. A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization. Anticancer Agents Med Chem. 2016;16:633-47 pubmed
  46. Chun Y, Oh H, Park M, Kim T, Chung S. Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C. J Neurodegener Dis. 2013;2013:407903 pubmed 出版商
  47. He C, Medley S, Hu T, Hinsdale M, Lupu F, Virmani R, et al. PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis. Nat Commun. 2015;6:7770 pubmed 出版商
  48. Popp M, Maquat L. Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics. Nat Commun. 2015;6:6632 pubmed 出版商
  49. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed 出版商
  50. Skelton L, Boron W. Effect of acute acid-base disturbances on the phosphorylation of phospholipase C-γ1 and Erk1/2 in the renal proximal tubule. Physiol Rep. 2015;3: pubmed 出版商
  51. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed 出版商
  52. Bilal M, Zhang E, Dinkel B, Hardy D, Yankee T, Houtman J. GADS is required for TCR-mediated calcium influx and cytokine release, but not cellular adhesion, in human T cells. Cell Signal. 2015;27:841-50 pubmed 出版商